Cargando…
IL-36β Promotes CD8(+) T Cell Activation and Antitumor Immune Responses by Activating mTORC1
Cytokine-amplified functional CD8(+) T cells ensure effective eradication of tumors. Interleukin 36α (IL-36α), IL-36β, and IL-36γ share the same receptor complex, composed of the IL-36 receptor (IL-36R), and IL-1RAcP. Recently, we revealed that IL-36γ greatly promoted CD8(+) T cell activation, contr...
Autores principales: | Zhao, Xin, Chen, Xiaojuan, Shen, Xinghua, Tang, Peijun, Chen, Chen, Zhu, Qitai, Li, Muyao, Xia, Rui, Yang, Xi, Feng, Chao, Zhu, Xinguo, Zhu, Yibei, Sun, Zhongwen, Zhang, Xueguang, Lu, Binfeng, Wang, Xuefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692458/ https://www.ncbi.nlm.nih.gov/pubmed/31447838 http://dx.doi.org/10.3389/fimmu.2019.01803 |
Ejemplares similares
-
LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control
por: Gan, Wenjian, et al.
Publicado: (2020) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors
por: Zhu, Ping Jun, et al.
Publicado: (2018) -
LPS Induces mTORC1 and mTORC2 Activation During Monocyte Adhesion
por: Ribeiro, Marcelle C., et al.
Publicado: (2018) -
Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication
por: Kuss-Duerkop, Sharon K., et al.
Publicado: (2017)